Ahmed A Abulfathi

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Acinetobacter Baumannii

Clinical Decision Support

Pulmonary Tuberculosis

Top Venues

Journal of clinical pharmacology

European journal of clinical pharmacology

British journal of clinical pharmacology

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa López-Varela, Ahmed A Abulfathi, Natasha Strydom, Pierre Goussard, Abraham C van Wyk, Anne Marie Demers, Anneen Van Deventer, Anthony J Garcia-Prats, Johannes van der Merwe, Matthew Zimmerman, Claire L Carter, Jacques Janson, Julie Morrison, Helmuth Reuter, Eric H Decloedt, James A Seddon, Elin M Svensson, Rob Warren, Radojka M Savic, Véronique Dartois, Anneke C Hesseling
Drug concentration at the site of disease in children with pulmonary tuberculosis. The Journal of antimicrobial chemotherapy 77 (6) (2022)
Ahmed A Abulfathi, Piyanan Assawasuwannakit, Peter R Donald, Andreas H Diacon, Helmuth Reuter, Elin M Svensson
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens. European journal of clinical pharmacology 76 (11) (2020)
Ahmed A Abulfathi, Peter R Donald, Kim Adams, Elin M Svenson, Andreas H Diacon, Helmuth Reuter
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance. British journal of clinical pharmacology 86 (11) (2020)
Kim T Adams, Peter R Donald, Ahmed A Abulfathi, Andreas H Diacon, Marietjie A Stander, Helmuth Reuter
Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance. Journal of clinical pharmacology 60 (4) (2019)
Ahmed A Abulfathi, Maxwell Chirehwa, Bernd Rosenkranz, Eric H Decloedt
Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations. Journal of clinical pharmacology 58 (9) (2018)